Seed · Healthtech · Athens, Greece · Founded 2016 · 51–100 employees
PNOĒ revolutionizes health optimization through clinical-grade breath analysis technology, making advanced metabolic testing accessible beyond elite clinics. Founded by two Greek engineers in 2016, the company has democratized breath analysis (VO2 Max testing) that was previously only available in sophisticated medical facilities. The company has raised $10.7M in funding and serves over 40,000 individuals and 1,000+ facilities globally, including world champions and leading institutions like MIT, UCLA, and Paris Saint Germain. PNOĒ was recognized as the #49 fastest growing company in the Americas for 2023 according to the Financial Times and participated in Y Combinator's Winter 2019 batch.